Back to search

Article

Paradoxical Activation of GCN2 by ATP-competitive inhibitors via allosteric activation and autophosphorylation

2024-08-14

Abstract excerpt

Recently it has been found that General Control Non-derepressible 2 (GCN2) can be activated by an array of small molecule ATP-competitive inhibitors, including clinically relevant compounds such as Ponatinib, and compounds specifically designed to be GCN2 inhibitors, such as GCN2iB. Furthermore, we recently showed that GCN2 can be activated in cells by clinically approved small molecule RAF inhibitors. GCN2 is a d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
baed9bdc-3a3b-563b-b506-2aec894bd152
DOI
10.1101/2024.08.14.606984
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Paradoxical Activation of GCN2 by ATP-competitive inhibitors via allosteric activation and autophosphorylationDOI 10.1101/2024.08.14.606984
Select a neighboring publication to make it the new centre.